ArticlePain reports2026
Long-term examination of pain and health-related outcomes in people with fibromyalgia before, during, and after COVID-19.
Article in Pain reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
- Commented on by
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Since the outbreak of COVID-19, many studies have investigated long-term consequences associated to the pandemic. Undoubtedly, restrictions and changes in everyday life during that time have had a broad impact on mental health and well-being, particularly in vulnerable populations, such as chronic pain patients. Objectives: The aim of this study was to examine longitudinal progression of pain-related outcomes in patients with fibromyalgia (FM). Methods: Using a repeated measures design with comparative data acquired before (T1) and during the pandemic (T2), as well as data from a recent survey (T3), this study investigated long-term development of pain symptoms and well-being in FM (N = 75) throughout and beyond the pandemic. For this purpose, longitudinal changes of clinical parameters, such as pain severity, disability, and depressive mood, as well as self-perceived changes of pain, anxiety, depression, and physical activity were assessed. Results: Patients displayed significant self-perceived worsening of pain compared with both preceding survey periods. However, these self-perceived changes were not reflected in longitudinal increases of pain values. Pain-related interference, perceived helplessness, and social activity levels were significant predictors of pain severity at T3, when using only T3 determinants as predictors. On the other hand, with regard to the prepandemic and pandemic period, past pain levels (T1, T2) and affective distress experienced at T2 were significant predictors of T3 pain. Conclusions: These findings emphasize the importance of psychosocial factors for the long-term progression of pain symptoms. In addition, our data suggest remarkable long-term stability of pain symptoms, despite repeated evidence for a self-perceived worsening of pain.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.